- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PR-171
Total 3603 results
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | ISS Stage III Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); AmgenActive, not recruitingPlasma Cell MyelomaUnited States
-
University of California, San FranciscoNational Comprehensive Cancer NetworkCompletedLymphoma | Lymphoma, Non-HodgkinUnited States
-
AmgenCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteAmgenCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Criterium, Inc.AmgenCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Attaya SuvannasankhaNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
Vedic Lifesciences Pvt. Ltd.Completed
-
Fu Jen Catholic UniversityRecruiting
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly
-
GenethonActive, not recruitingLGMD2IDenmark, France, United Kingdom
-
University Hospital, BrestRecruitingPulmonary Embolism | Quality of Life and DyspneaFrance
-
McMaster UniversityRecruiting
-
University of British ColumbiaCompletedCardiorespiratory FitnessCanada
-
Chang Gung Memorial HospitalUnknown
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknown
-
ReNeuron LimitedActive, not recruitingRetinitis PigmentosaUnited States, United Kingdom, Spain
-
Swiss Group for Clinical Cancer ResearchTerminated
-
Chong Kun Dang PharmaceuticalCompletedImmunosuppressant(Organ Transplantation, RA)
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Ewha Womans UniversityCompletedOsteoarthritisKorea, Republic of
-
Legacy Health SystemTerminatedMetastatic Breast CancerUnited States
-
Ain Shams UniversityCompletedCombined Ring (APR) Fixation Vs Posterior Ring Fixation in Tile B2 and C1 Pelvic Ring Injuries (APR)Evaluation of PR Fixation in Tile B2 and C1 InjuriesEgypt
-
Peregrine PharmaceuticalsWithdrawnBreast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
-
Grünenthal GmbHCompleted
-
Johns Hopkins UniversityCompleted
-
Mundipharma Research GmbH & Co KGCompletedConstipationRomania, Switzerland, Israel, Belgium, Germany, Australia, Austria, Czech Republic, Denmark, Finland, France, Netherlands, Poland, United Kingdom
-
University of CopenhagenCompleted
-
Göteborg UniversityCompletedBehavior Problem of Childhood and Adolescence
-
University of PennsylvaniaRecruiting
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceRecruiting
-
BioprojetCompletedEfficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease (HARPS1)Parkinson's DiseaseFrance
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Columbia UniversityNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Sociedad Española de Neumología y Cirugía TorácicaCompletedSuspected Sleep Apnea | Daytime SleepinessSpain
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)RecruitingObesity | Obstructive Sleep ApneaUnited States
-
Göteborg UniversityRecruitingNeurodevelopmental Disorders | Behavior ProblemsSweden
-
University of AlbertaUniversity of CalgaryCompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
LivaNovaCompletedHeart FailureUnited States, Canada, France, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom